{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:2156"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:2156","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Recombinant antibodies against Clostridium difficile toxin A","abstract":"The carboxy-terminal region of Clostridium difficile Toxin A was expressed as a recombinant protein (ToxinA-CT), purified, and shown to behave as would be expected of the receptor-binding domain. ToxinA-CT was then used to isolate scFv antibodies from a phage display library using conventional bio-panning methods. Progressive enrichment of ToxinA-CT-specific scFvs through 3 rounds of selection was observed. Those scFvs that showed strongest reaction with ToxinA-CT in ELISA were sequenced, expressed as soluble antibodies and purified. A panel of diverse scFvs was established that appeared to bind to non-overlapping epitopes on ToxinA-CT. To assay for protective activity, scFvs were mixed with native Toxin A, added to cells in culture, and the response monitored over a 2 hour period. The scFvs were added to consistently delay the cytopathic activity of Toxin A but were unable to match the neutralizing activity of a polyclonal serum or its Fab derivatives. The epitopes recognised by the scFvs were localized using a sub-cloning strategy. Defined parts of the ToxinA-CT reading frame were recovered by PCR and fusions created with maltose binding protein. scFvs were tested for recognition of the maltose binding fusion proteins. In one instance, a scFv reacted with multiple fusion proteins suggesting recognition of a repeated peptide motif. A maltose binding protein fusion carrying a candidate sequence was successfully recognised by this scFv. Overall, phage display enabled assembly of a panel of scFv antibodies against epitopes in the carboxy-terminal domain of Toxin A. The inability of these antibodies to block the activity of Toxin A may be due to the multivalent interaction between the toxin and its receptor. Alternatively, the ToxinA-CT used in scFv isolated may lack functions that are crucial for receptor interaction and hence potential targets for antibody-mediated inhibition.","abstract_html":"The carboxy-terminal region of Clostridium difficile Toxin A was expressed as a recombinant protein (ToxinA-CT), purified, and shown to behave as would be expected of the receptor-binding domain. ToxinA-CT was then used to isolate scFv antibodies from a phage display library using conventional bio-panning methods. Progressive enrichment of ToxinA-CT-specific scFvs through 3 rounds of selection was observed. Those scFvs that showed strongest reaction with ToxinA-CT in ELISA were sequenced, expressed as soluble antibodies and purified. A panel of diverse scFvs was established that appeared to bind to non-overlapping epitopes on ToxinA-CT. To assay for protective activity, scFvs were mixed with native Toxin A, added to cells in culture, and the response monitored over a 2 hour period. The scFvs were added to consistently delay the cytopathic activity of Toxin A but were unable to match the neutralizing activity of a polyclonal serum or its Fab derivatives. The epitopes recognised by the scFvs were localized using a sub-cloning strategy. Defined parts of the ToxinA-CT reading frame were recovered by PCR and fusions created with maltose binding protein. scFvs were tested for recognition of the maltose binding fusion proteins. In one instance, a scFv reacted with multiple fusion proteins suggesting recognition of a repeated peptide motif. A maltose binding protein fusion carrying a candidate sequence was successfully recognised by this scFv. Overall, phage display enabled assembly of a panel of scFv antibodies against epitopes in the carboxy-terminal domain of Toxin A. The inability of these antibodies to block the activity of Toxin A may be due to the multivalent interaction between the toxin and its receptor. Alternatively, the ToxinA-CT used in scFv isolated may lack functions that are crucial for receptor interaction and hence potential targets for antibody-mediated inhibition.","abstract_has_math":false,"creators":["Alkhalifah, Mohammed Ali"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2007,"date_issued":"2007","date_published":"2007","updated_at":"2026-11-19T08:20:19Z","subjects":["QR180 Immunology"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://theses.gla.ac.uk/2156/1/2007alkhalifahphd.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A2156","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Alkhalifah, Mohammed Ali"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2007"]},{"key":"dc:date.issued","label":"Date","values":["2007"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/2156/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/229410857"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QR180 Immunology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/2156/1/2007alkhalifahphd.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The carboxy-terminal region of Clostridium difficile Toxin A was expressed as a recombinant protein (ToxinA-CT), purified, and shown to behave as would be expected of the receptor-binding domain. ToxinA-CT was then used to isolate scFv antibodies from a phage display library using conventional bio-panning methods. Progressive enrichment of ToxinA-CT-specific scFvs through 3 rounds of selection was observed. Those scFvs that showed strongest reaction with ToxinA-CT in ELISA were sequenced, expressed as soluble antibodies and purified. A panel of diverse scFvs was established that appeared to bind to non-overlapping epitopes on ToxinA-CT. To assay for protective activity, scFvs were mixed with native Toxin A, added to cells in culture, and the response monitored over a 2 hour period. The scFvs were added to consistently delay the cytopathic activity of Toxin A but were unable to match the neutralizing activity of a polyclonal serum or its Fab derivatives. The epitopes recognised by the scFvs were localized using a sub-cloning strategy. Defined parts of the ToxinA-CT reading frame were recovered by PCR and fusions created with maltose binding protein. scFvs were tested for recognition of the maltose binding fusion proteins. In one instance, a scFv reacted with multiple fusion proteins suggesting recognition of a repeated peptide motif. A maltose binding protein fusion carrying a candidate sequence was successfully recognised by this scFv. Overall, phage display enabled assembly of a panel of scFv antibodies against epitopes in the carboxy-terminal domain of Toxin A. The inability of these antibodies to block the activity of Toxin A may be due to the multivalent interaction between the toxin and its receptor. Alternatively, the ToxinA-CT used in scFv isolated may lack functions that are crucial for receptor interaction and hence potential targets for antibody-mediated inhibition."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Recombinant antibodies against Clostridium difficile toxin A"]}]}],"canonical_facts":{"dc:creator":["Alkhalifah, Mohammed Ali"],"dc:date":["2007"],"dc:date.issued":["2007"],"dc:description.abstract":["The carboxy-terminal region of Clostridium difficile Toxin A was expressed as a recombinant protein (ToxinA-CT), purified, and shown to behave as would be expected of the receptor-binding domain. ToxinA-CT was then used to isolate scFv antibodies from a phage display library using conventional bio-panning methods. Progressive enrichment of ToxinA-CT-specific scFvs through 3 rounds of selection was observed. Those scFvs that showed strongest reaction with ToxinA-CT in ELISA were sequenced, expressed as soluble antibodies and purified. A panel of diverse scFvs was established that appeared to bind to non-overlapping epitopes on ToxinA-CT. To assay for protective activity, scFvs were mixed with native Toxin A, added to cells in culture, and the response monitored over a 2 hour period. The scFvs were added to consistently delay the cytopathic activity of Toxin A but were unable to match the neutralizing activity of a polyclonal serum or its Fab derivatives. The epitopes recognised by the scFvs were localized using a sub-cloning strategy. Defined parts of the ToxinA-CT reading frame were recovered by PCR and fusions created with maltose binding protein. scFvs were tested for recognition of the maltose binding fusion proteins. In one instance, a scFv reacted with multiple fusion proteins suggesting recognition of a repeated peptide motif. A maltose binding protein fusion carrying a candidate sequence was successfully recognised by this scFv. Overall, phage display enabled assembly of a panel of scFv antibodies against epitopes in the carboxy-terminal domain of Toxin A. The inability of these antibodies to block the activity of Toxin A may be due to the multivalent interaction between the toxin and its receptor. Alternatively, the ToxinA-CT used in scFv isolated may lack functions that are crucial for receptor interaction and hence potential targets for antibody-mediated inhibition."],"dc:format":["application/pdf"],"dc:identifier.uri":["https://theses.gla.ac.uk/2156/1/2007alkhalifahphd.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/2156/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/229410857"],"dc:subject":["QR180 Immunology"],"dcterms:accessrights":["public"],"dc:title":["Recombinant antibodies against Clostridium difficile toxin A"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:20:19Z"}